Core One Labs Inc. (CSE: COOL | OTCQB: CLABF | Frankfurt: LD6, WKN: A3CSSU) the Company is pleased to announce that its wholly-owned subsidiary, Vocan...
The article Mydecine Closes Sale of Mindleap for $3.6 million was originally published on Microdose. Starting this summer, we began reporting on the apparent...
The company filed provisional patents for the use of psilocybin to treat binge eating disorder and fibromyalgia. The post Tryp’s Clinical Psychedelics...
Source: Streetwise Reports 12/12/2022 Clinical-stage Algernon Pharmaceuticals' multiple pipelines include testing a psychedelic for the treatment...
The article Awakn’s Phase 3 Trial Launching With UK National Health Service was originally published on Microdose. Awakn Life Sciences has announced...
Awakn Life Sciences Corp. (NEO: AWKN | OTCQB: AWKNF | FSE: 954), a revenue-generating biotechnology company researching, developing, and commercializing...
Filament Health (OTCQB:FLHLF | NEO:FH | FSE:7QS), a clinical stage natural psychedelic drug development company, today announced that Benjamin Lightburn,...
The article News You Might Have Missed: Dec 12th 2022 was originally published on Microdose. Welcome to the News You Might Have Missed, a weekly...
Let’s get straight to it: The psychedelic stock market continues to underperform. Taking a look at our Psychedelic Invest Index, we can see that only...
Irwin Naturals Inc. (CSE: IWIN | OTC: IWINF | FRA: 97X) completed the acquisition of the assets of Clare Clinic, Inc., d/b/a Florida Mind Health Center....